Blistering Papulosquamous Erythema with Arthralgia: A Quiz
DOI:
https://doi.org/10.2340/actadv.v102.936Abstract
Abstract is missing (Quiz)
Downloads
References
Hubner F, Langan EA, Recke A. Lichen planus pemphigoides: from lichenoid inflammation to autoantibody-mediated blistering. Front Immunol 2019; 10: 1389.
https://doi.org/10.3389/fimmu.2019.01389 DOI: https://doi.org/10.3389/fimmu.2019.01389
Zillikens D, Caux F, Mascaro JM, Wesselmann U, Schmidt E, Prost C, et al. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180. J Invest Dermatol 1999; 113: 117-121.
https://doi.org/10.1046/j.1523-1747.1999.00618.x DOI: https://doi.org/10.1046/j.1523-1747.1999.00618.x
Gawkrodger DJ, Stavropoulos PG, McLaren KM, Buxton PK. Bullous lichen planus and lichen planus pemphigoides - clinico-pathological comparisons. Clin Exp Dermatol 1989; 14: 150-153.
https://doi.org/10.1111/j.1365-2230.1989.tb00914.x DOI: https://doi.org/10.1111/j.1365-2230.1989.tb00914.x
Yamashita C, Arase N, Higuchi S, Arase H, Takagi J, Nojima S, et al. Serum autoantibodies against the extracellular region of alpha6beta4 integrin in a patient with dipeptidyl peptidase-4 inhibitor-induced bullous pemphigoid. JAAD Case Rep 2022; 20: 65-68.
https://doi.org/10.1016/j.jdcr.2021.12.021 DOI: https://doi.org/10.1016/j.jdcr.2021.12.021
Liu Y, Soh WT, Kishikawa JI, Hirose M, Nakayama EE, Li S, et al. An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies. Cell 2021; 184: 3452-3466.e8.
https://doi.org/10.1016/j.cell.2021.05.032 DOI: https://doi.org/10.1016/j.cell.2021.05.032
Tomayko MM, Damsky W, Fathy R, McMahon DE, Turner N, Valentin MN, et al. Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination. J Allergy Clin Immunol 2021; 148: 750-751.
https://doi.org/10.1016/j.jaci.2021.06.026 DOI: https://doi.org/10.1016/j.jaci.2021.06.026
Sato NA, Kano Y, Shiohara T. Lichen planus occurring after influenza vaccination: report of three cases and review of the literature. Dermatology 2010; 221: 296-299.
https://doi.org/10.1159/000321191 DOI: https://doi.org/10.1159/000321191
Rebora A, Rongioletti F, Drago F, Parodi. Lichen planus as a side effect of HBV vaccination. Dermatology 1999; 198: 1-2.
https://doi.org/10.1159/000018054 DOI: https://doi.org/10.1159/000018054
Laschinger ME, Schleichert RA, Green B. Lichenoid drug eruption after human papillomavirus vaccination. Pediatr Dermatol 2015; 32: e48-e49.
https://doi.org/10.1111/pde.12516 DOI: https://doi.org/10.1111/pde.12516
Farinazzo E, Ponis G, Zelin E, Errichetti E, Stinco G, Pinzani C, et al. Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from Northeast Italy. J Eur Acad Dermatol Venereol 2021; 35: e548-e551.
https://doi.org/10.1111/jdv.17343 DOI: https://doi.org/10.1111/jdv.17343
Larson V, Seidenberg R, Caplan A, Brinster NK, Meehan SA, Kim RH. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination. J Cutan Pathol 2022; 49: 34-41.
https://doi.org/10.1111/cup.14104 DOI: https://doi.org/10.1111/cup.14104
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med 2020; 383: 2603-2615.
https://doi.org/10.1056/NEJMoa2034577 DOI: https://doi.org/10.1056/NEJMoa2034577
Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol 2020; 217: 108480.
https://doi.org/10.1016/j.clim.2020.108480 DOI: https://doi.org/10.1016/j.clim.2020.108480
Witberg G, Barda N, Hoss S, Richter I, Wiessman M, Aviv Y, et al. Myocarditis after covid-19 vaccination in a large health care organization. N Engl J Med 2021; 385: 2132-2139.
https://doi.org/10.1056/NEJMoa2110737 DOI: https://doi.org/10.1056/NEJMoa2110737
Iketani S, Liu L, Nair MS, Mohri H, Wang M, Huang Y, et al. A third COVID-19 vaccine shot markedly boosts neutralizing antibody potency and breadth. medRxiv 2021.
https://doi.org/10.1101/2021.08.11.21261670 DOI: https://doi.org/10.1101/2021.08.11.21261670
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Yukiho Kurosaki, Yosuke Ishitsuka, Yasuhiro Kato, Noriko Arase, Manabu Fujiomto
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
